First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Update

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the recipient of a significant growth in short interest in December. As of December 31st, there was short interest totalling 1,500 shares, a growth of 275.0% from the December 15th total of 400 shares. Based on an average trading volume of 2,400 shares, the days-to-cover ratio is currently 0.6 days.

First Trust Nasdaq Pharmaceuticals ETF Stock Down 0.8 %

FTXH stock traded down $0.22 during trading on Monday, hitting $26.92. 116 shares of the company’s stock traded hands, compared to its average volume of 1,059. The firm has a market capitalization of $14.81 million, a P/E ratio of 15.98 and a beta of 0.70. The business has a fifty day simple moving average of $27.70 and a two-hundred day simple moving average of $28.24. First Trust Nasdaq Pharmaceuticals ETF has a 1 year low of $25.73 and a 1 year high of $29.72.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Tuesday, December 31st. Investors of record on Friday, December 13th were paid a dividend of $0.1304 per share. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13. The ex-dividend date of this dividend was Friday, December 13th.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.